BBT-059

N/A

Report date: 2022/05/10 11:42:43

Base Information

Drug NameBBT-059
Drug Alias NameBBT059
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukins replacements
TargetsInterleukins
Therapy Area/IndicationsAcute Radiation Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesBolder Biotechnology
Inactive CompaniesN/A
Active IndicationsAcute Radiation Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A